1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
ME/CFS: A disease at war with itself
We can all agree that ME/CFS is a nasty disease, particularly in its severe form, but there are abundant nasty diseases in the world. What is unique and particularly confounding about our disease is that so much controversy surrounds it, and not only surrounds it, but invades it too.
Discuss the article on the Forums.

Rituxan will be off patent in 2013 in Europe

Discussion in 'Rituximab: News and Research' started by fairlight, Jul 30, 2012.

  1. fairlight

    fairlight

    Messages:
    77
    Likes:
    0
  2. August59

    August59 Daughters High School Graduation

    Messages:
    1,480
    Likes:
    405
    Upstate SC, USA
    Rituximab is also in clinical trials for MS to, I think. Not sure what phase, but if they found enough uses for a generic rituximab it might make it profitable for someone to go after a generic version.
  3. shannah

    shannah Senior Member

    Messages:
    843
    Likes:
    175
  4. Sherlock

    Sherlock bicarb for exercise recovery and taming candida

    Messages:
    694
    Likes:
    237
    US
    Unfortunately, AFAIK no one is allowed still to make generic versions of biologic medications, even when off patent in the U.S. as per the FDA. The rationale is that they are too difficult to make properly.


    http://www.businessweek.com/stories...siness-news-stock-market-and-financial-advice

    more here: http://www.merckmanuals.com/home/drugs/trade-name_and_generic_drugs/generic_biologic_drugs.html

    But then, Europe and Mabthera might be different?

See more popular forum discussions.

Share This Page